.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cerilliant
Fish and Richardson
Argus Health
US Department of Justice
Deloitte
Merck
AstraZeneca
Citi
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

FREAMINE III 8.5% Drug Profile

« Back to Dashboard

When do Freamine Iii 8.5% patents expire, and what generic alternatives are available?

Freamine Iii 8.5% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE III 8.5% is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for FREAMINE III 8.5%

Drug patent expirations by year for FREAMINE III 8.5%

Pharmacology for FREAMINE III 8.5%

Ingredient-typeAmino Acids
Drug ClassAmino Acid

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
B BraunFREAMINE III 8.5%amino acidsINJECTABLE;INJECTION016822-004Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
B BraunFREAMINE III 8.5% W/ ELECTROLYTESamino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetateINJECTABLE;INJECTION016822-007Jul 1, 1988RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
UBS
Julphar
Express Scripts
Novartis
Fuji
Deloitte
Boehringer Ingelheim
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot